Literature DB >> 29316519

The regional homogeneity of cingulate-precuneus regions: The putative biomarker for depression and anxiety.

Chien-Han Lai1.   

Abstract

OBJECTIVES: In addition to clinical interview, the modern putative biomarker to differentiate depression and anxiety would be warranted. The translational medicine characteristics of neuroimaging, such as the regional homogeneity (ReHo), is an option for depression and anxiety. Therefore we designed this study trying to identify the biomarker pattern for depression and anxiety.
METHODS: Resting-state functional magnetic resonance imaging was acquired for 53 patients with first-episode medicine-naïve major depressive disorder (MDD), 53 first-episode medicine-naïve patients with panic disorder (PD) and 54 controls. The calculation of ReHo was performed. The ANOVA repeated measures were applied for the 3 groups to investigate the putative differences between MDD and PD (FDR corrected p < 0.05).
RESULTS: After multiple comparisons, the major findings of ReHo were found in the bilateral anterior cingulate cortex and bilateral precuneus. MDD group had lower ReHo values than PD group in the left anterior cingulate cortex. MDD group had significant alterations of ReHo in the left anterior cingulate cortex and bilateral precuneus when compared to controls. PD group had alterations in the bilateral precuneus when compared to controls.
CONCLUSION: The specific cingulate alterations might be a putative ReHo biomarker to differentiate MDD from PD in cingulate-precuneus background for ReHo alterations.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anterior cingulate cortex; Major depressive disorder; Panic disorder; Precuneus; Regional homogeneity

Mesh:

Substances:

Year:  2018        PMID: 29316519     DOI: 10.1016/j.jad.2017.12.086

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Hyperconnectivity between the posterior cingulate and middle frontal and temporal gyrus in depression: Based on functional connectivity meta-analyses.

Authors:  Ziqing Zhu; You Wang; Way K W Lau; Xinhua Wei; Yingjun Liu; Ruiwang Huang; Ruibin Zhang
Journal:  Brain Imaging Behav       Date:  2022-01-28       Impact factor: 3.224

2.  Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder.

Authors:  Kaiping Burrows; Jennifer L Stewart; Rayus Kuplicki; Leandra Figueroa-Hall; Philip A Spechler; Haixia Zheng; Salvador M Guinjoan; Jonathan B Savitz; T Kent Teague; Martin P Paulus
Journal:  Brain Behav Immun       Date:  2021-01-26       Impact factor: 19.227

3.  Promising Neuroimaging Biomarkers in Depression.

Authors:  Chien-Han Lai
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

4.  Altered Cingulum Functioning in Major Depressive Disorder Patient With Suicide Attempts: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  Chunxia Yang; Yajuan Duan; Lei Lei; Penghong Liu; Aixia Zhang; Gaizhi Li; Ning Sun; Yikun Wang; Zhifen Liu; Kerang Zhang
Journal:  Front Neurosci       Date:  2022-03-28       Impact factor: 4.677

5.  A multimodal study regarding neural correlates of the subjective well-being in healthy individuals.

Authors:  Hye-Yeon Jung; Chongwon Pae; Iseul An; Minji Bang; Tai Kiu Choi; Sung Joon Cho; Sang-Hyuk Lee
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

6.  Altered spontaneous neural activity in the precuneus, middle and superior frontal gyri, and hippocampus in college students with subclinical depression.

Authors:  Bo Zhang; Shouliang Qi; Shuang Liu; Xiaoya Liu; Xinhua Wei; Dong Ming
Journal:  BMC Psychiatry       Date:  2021-06-01       Impact factor: 3.630

7.  Changes in Resting-State Spontaneous Brain Activity in Patients With Allergic Rhinitis: A Pilot Neuroimaging Study.

Authors:  Ziang Gao; Xixiang Chen; Rong Xiang; Wei Zhang; Lu Tan; Wenjun Fan; Peiqiang Liu; Hao Lv; Yu Xu
Journal:  Front Neurosci       Date:  2021-07-14       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.